Day: June 21, 2022

Capelle aan den IJssel, the Netherlands, 21 June 2022 – Location and mapping technology has always and will continue to play an important role in solving the biggest environmental problems that we are facing today. Addressing climate challenges in this location-first world that thrives on movement — be it people, goods or resources — calls for innovative geospatial solutions.  The partnership between NextBillion.ai, an industry-leading spatial data + AI platform and GeoJunxion (GOJXN.AS), the leading Low Emission Zones and Restricted Traffic Areas data provider is proof of that. This strategic cooperation will help to improve the effectiveness of the Low Emission Zone (LEZ) — an initiative that is designed to protect the environment. First routing platform designed for LEZAt present, delivery companies pay hundreds of thousands of euros...

CHARLOTTE, N.C., June 21, 2022 (GLOBE NEWSWIRE) — Amergent Hospitality Group (OTCQB:AMHG) (“Amergent” or the “Company”), owner, operator and franchisor of multiple nationally-recognized restaurant, today announced the launch of its Little Big Burger national franchising campaign, led by recently appointed Mark Whittle, EVP of Franchise and Development. “The Little Big Burger brand is time tested and continues to deliver strong financial performance. Its highly scalable fast casual business model is ideally suited for franchising with its efficient and flexible design, simplified menu, compelling unit level economics, broad demographic appeal and superior franchise support structure. We have a strong foundation to leverage, which will enable me to do what I have done my entire career, grow the franchise side of...

FORT LEE, NJ,, June 21, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that the U.S. Food and Drug Administration (“FDA”) cleared the Company’s Investigational New Drug Application (“IND”) for NXP800, which includes the Phase 1 clinical trial protocol. The NXP800 Phase 1 clinical trial is comprised of two parts, a dose escalation study (“Phase 1a”) to be followed by an expansion study (“Phase 1b”). The Phase 1a is currently ongoing in the United Kingdom (“U.K.”) and, with the IND in effect, U.S. clinical sites will now be included. The Company expects to initiate the Phase 1b study in early 2023. “The FDA approval of the...

RICHLAND, Wash., June 21, 2022 (GLOBE NEWSWIRE) — The growing body of information regarding Isoray, Inc.’s (NYSE American: ISR) Cesium-131 in treating prostate cancer was highlighted in two presentations at the just concluded American Brachytherapy Society’s annual conference in Denver, Colorado. During the conference, the Prostate Snap Oral I scientific session included two abstracts that were presented by The Cesium Advisory Group. The group is comprised of five experienced physicians with extensive experience using Cesium-131 monotherapy for permanent prostate brachytherapy who came together to form the advisory group. Commenting on the presentations, Isoray CEO Lori Woods said, “Long-term outcomes have demonstrated the significance of Cesium-131 brachytherapy for prostate cancer treatment. These abstracts present valuable information...

LAS VEGAS and MANITOWOC, Wis., June 21, 2022 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting and control systems, including turnkey project implementation, program management and system maintenance, announced it will be exhibiting its energy-efficient LED lighting products at the LIGHTFAIR® 2022 International trade show and conference (booth #3301) at the Las Vegas Convention Center – West Hall from Tuesday, June 21st through Thursday, June 23rd. Orion will host an informal investor booth tour with management Q&A on Tuesday, June 21st from 3:30 to 4:30 pm PT. Investors should confirm their attendance in advance by contacting Orion’s Investor Relations team (contact information below). Mike Altschaefl, Orion CEO, commented, “We are very happy...